(Date:10/10/2008)...of Health (NIH) scientists have identified a prote...white blood cells, T and B cells, enabling them to... long-lasting immunity after an infection. Their ...have a genetic defect that prevents them from maki...ions with a common virus that otherwise is rarely ...
(Date:10/10/2008)... Oct. 10 /PRNewswire-FirstCall/ -- Accuray,Incorpo...ld of radiosurgery,today announced that it will r...09, ending September 27, 2008, on Wednesday, Octob...e call to review the results will begin at 2:00 p....S. Thomson, Ph.D., president and,chief executive o...
(Date:10/9/2008)...pecialists Will Give Accredited Course for,Non-Der...noma, To be held November 1, 2008 at the Royal So..., Oct. 9 /PRNewswire-USNewswire/ -- The Melanoma,F... School of Medicine are,co-sponsoring an Accredita...ME) course to update non-dermatologists on the det...
(Date:10/9/2008)...Newswire/ -- After a thorough review of multiple,c... Services (VDSS),announced that it has selected Po...e child support offices in the Chesapeake and Hamp... and human services for government,clients. The co...lly and,will run through January 2014., VDSS cite...
Breaking Medicine News(10 mins):Health News:NIH scientists discover crucial control in long-lasting immunity 2Health News:NIH scientists discover crucial control in long-lasting immunity 3Health News:Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results 2Health News:Paul Sullivan's Legacy: An Early Warning Program for Detecting Melanoma Before It's Too Late 2Health News:PSI Selected to Operate Virginia's Child Support Program in Chesapeake and Hampton 2(Date:10/10/2008)...ewswire-FirstCall/ -- Inverness Medical,Innovation...patient,diagnostics, monitoring and health managem... Secretary-General of the United Nations, as part ...e world,s leading,research-based and generic pharm...ether with senior officials from the United Nation...
(Date:10/9/2008)...pread Awareness and Bring Hope to Millions,of Chil...wswire/ -- 133 million children,across the globe a...ural,disaster, civil war, and disease. SOS Childre...an Week by calling attention to the needs of orpha...e, go to:, http://www.prnewswire.com/mnr/soschil...
(Date:10/9/2008)...pected in November 2008, BOTHELL, Wash., Oct. 9 /... DDD ) announced today the completion of patient ...ivotal trials to evaluate the safety and,efficacy ...) ibuprofen for,the over-the-counter (OTC) market....om this pivotal trial in November 2008. Ibuprofen ...
(Date:10/8/2008)...ewswire-USNewswire/ -- The facts are,overwhelming....in,sub-Saharan Africa. More than 35,000,000 women,...ady died of AIDS. The Foundation for Hospices,in S...nd their families,find compassion and relief from ...artnering initiative links African hospices and pa...
Breaking Medicine Technology:Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4U of T discovers environmental factors linked to sex ratio of plants 4147 1BCBSNC Makes Electronic Prescribing Available Statewide 24262 1BCBSNC Makes Electronic Prescribing Available Statewide 24262 2BCBSNC Makes Electronic Prescribing Available Statewide 24262 3BCBSNC Makes Electronic Prescribing Available Statewide 24262 4Jennerex Publishes Clinical Trial Data With Lead Product JX 594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2685 1Jennerex Publishes Clinical Trial Data With Lead Product JX 594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2685 2Jennerex Publishes Clinical Trial Data With Lead Product JX 594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2685 3Jennerex Publishes Clinical Trial Data With Lead Product JX 594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2685 4Has cancer spread 3F Research identifies best way to find answers so treatment can begin 24260 1Has cancer spread 3F Research identifies best way to find answers so treatment can begin 24260 2...WIRE)--Jun 12, 2007 - Inspire,Pharmaceuticals, Inc...nd collaborators related to Inspire will present,i...ademy of,Allergology and Clinical Immunology (EAAC...and at the 30th European Cystic Fibrosis,Society (...lek,Turkey., The EAACI Congress includes two pres...
...d both primary and secondary endpoints of,study; n...een,valopicitabine and ribavirin ~, CAMBRIDGE, Mas...,Pharmaceuticals, Inc. today announced results fro...bination therapy, consisting of,valopicitabine (NM...nt of hepatitis C, pegylated interferon and ribavi...
Other Medicine Technology:Inspire Announces Presentations at Two European Scientific,Conferences 2Inspire Announces Presentations at Two European Scientific,Conferences 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6The very popular and competitively priced SportNeb features a 35 PSI, die-cast aluminum compressor. Design enhancements include a neb kit holder, built-in cord storage and optional black carry bag. T
...act Compressor provides effective therapy at an af...r therapy at home or on the go and features ease o...eration you have come to count on from DeVilbiss.,... solution for those patients seeking a quality, ef...
...unit with a unique docking port to hold a Salter N...integrated uni-position for quiet, powerful operat...mbinations with Salter Nebulizers, Masks and Mouth...le. , ,The Salter AIRE Plus® Compressor (115...
Whether you require high flow rates for critical situations or lower rates for others, this insufflator handles both situations equally well, regulated by the preselected pressure.
Medicine Products: